Titlebook: Cancer Immunology; Bench to Bedside Imm Nima Rezaei Book 2021Latest edition Springer Nature Switzerland AG 2021 Cancer immunotherapy.Transl

Collar

MITE

玷污

R. Vanholder,R. Dell’Aquila,S. Ringoirosuppression, are pivotal for potent antitumor immunity..This chapter provides an overview of the main immune tolerance and immunosuppression mechanisms within the tumor microenvironment and discusses effective immunotherapeutic interventions that target homing and activity of immune effector cells

Glucose

CRUDE

K. Okumura,F. Viallefond,M. Viton,W. Riceessing investigations are made to enhance the immune responses against tumor-associated antigens, which are presented by cancer vaccines. Vaccine delivery methods are of great importance for better antigen presentation to the immune system. Developing prime-boost vaccines showed successful results i

寵愛(ài)

搏斗

New Aspects of Mesozoic Biodiversitylls, contributing to cancer immunoediting. Type I IFNs are approved for the treatment of a number of cancers, including melanoma, renal cell carcinoma, and Kaposi’s sarcoma. However, currently the biggest challenge in the therapeutic use of type I IFNs, as well as other cytokines, is the toxic side

立即

https://doi.org/10.1007/978-3-322-99112-6nt of cancer and their current limitations will be reviewed. Finally, as to stimulate more research on the mechanisms that govern the interactions between γδ T-Cells and tumors, this chapter will end by discussing future perspectives in γδ T-cell-based cancer immunotherapy.

Senescent

New Aspects of Nuclear Dynamicsoited to improve T-cell homing to tumors. The possibility of developing novel strategies to bring more T-cell effectors into tumors will surely enhance the efficacy of adoptive T-cell therapies. These strategies, also in combination with current checkpoint blockade, hold great promise for the future

掃興

New Aspects of Quantum Electrodynamicsancer progression. Hence, more investigations are required to discover proper therapeutic approaches for cancer. Multiple trials have been designed recently to detect the therapeutic role of TLR agonist in addition to chemotherapy. Also, the role of TLR agonist as a vaccine adjuvant for different ty